v3.26.1
Insider Trading Arrangements
3 Months Ended
Jun. 30, 2026
shares
Trading Arrangements, by Individual  
Non-Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Terminated false
Hunter Smith [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
On May 13, 2026, Hunter Smith, the Company's Chief Financial Officer, adopted a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act for the sale of up to 62,774 shares of the Company's common stock as well as up to 100% of the shares of our common stock issued to Mr. Smith upon the settlement of outstanding restricted stock units, less the number of shares surrendered to the issuer or sold to cover tax withholding obligations in connection with the vesting and settlement of such restricted stock units, until May 12, 2027.
Name Hunter Smith
Title Company's Chief Financial Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date May 13, 2026
Expiration Date May 12, 2027
Arrangement Duration 364 days
Aggregate Available 62,774
Yann Mazzabraud [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
On May 13, 2026, Yann Mazzabraud, the Company's Executive Vice President, Head of International, adopted a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act for the sale of up to 57,000 shares of the Company's common stock until August 15, 2027.
Name Yann Mazzabraud
Title Company's Executive Vice President, Head of International
Rule 10b5-1 Arrangement Adopted true
Adoption Date May 13, 2026
Expiration Date August 15, 2027
Arrangement Duration 459 days
Aggregate Available 57,000
Alastair Garfield [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
On May 14, 2026, Alastair Garfield, the Company's Chief Scientific Officer, adopted a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act for the sale of up to 7,763 shares of the Company's common stock until February 13, 2027.
Name Alastair Garfield
Title Company's Chief Scientific Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date May 14, 2026
Expiration Date February 13, 2027
Arrangement Duration 275 days
Aggregate Available 7,763
Jennifer Lee [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
On May 14, 2026, Jennifer Lee, the Company's Executive Vice President, Head of North America, adopted a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act for the sale of up to 76,201 shares of the Company's common stock as well as up to 100% of the shares of our common stock issued to Ms. Lee upon the settlement of outstanding restricted stock units, less the number of shares surrendered to the issuer or sold to cover tax withholding obligations in connection with the vesting and settlement of such restricted stock units, until March 1, 2027.
Name Jennifer Lee
Title Company's Executive Vice President, Head of North America
Rule 10b5-1 Arrangement Adopted true
Adoption Date May 14, 2026
Expiration Date March 1, 2027
Arrangement Duration 291 days
Aggregate Available 76,201
David Meeker [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
On June 15, 2026, David Meeker, the Company's Chief Executive Officer, adopted a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act for the sale of up to 300,000 shares of the Company's common stock until March 15, 2027.
Name David Meeker
Title Company's Chief Executive Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date June 15, 2026
Expiration Date March 15, 2027
Arrangement Duration 273 days
Aggregate Available 300,000
Lynn Tetrault [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
On June 24, 2026, Lynn Tetrault, a member of the Company’s Board of Directors, terminated a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act, which was previously adopted on December 15, 2025 and provided for the sale of up to 55,000 shares of the Company’s common stock until September 16, 2026.
Name Lynn Tetrault
Title member of the Company’s Board of Directors
Rule 10b5-1 Arrangement Terminated true
Termination Date June 24, 2026
Aggregate Available 55,000